Abstract
Alginate–chitosan nanocapsules (Alg-CS NCs) were prepared by a two-stage process. The NCs were loaded with two low molecular drugs-tegafur and Mitoxantrone Hydrochloride(DHAD). Results revealed that these two drugs exhibited different drug loading and release characteristics. The drug loading and encapsulation efficiency of tegafur (<1%) were both lower than those of DHAD with the drug loading at about 20%~60% and encapsulation efficiency over 90%. However, tegafur showed a visible burst release phenomenon and the cumulative release rate of tegafur was much higher than that of DHAD.
Publisher
Trans Tech Publications, Ltd.
Reference26 articles.
1. L.F. Weikersthal, A. Schalhorn, M. Stauch, et al: European Journal of Cancer Vol. 47 (2011), p.206.
2. A. Torre, J. Romero, A. Montero, et al: Tumori Vol. 94 (2008), p.453.
3. K. Katsumata, H. Tomioka, M. Kusama, et al: Cancer Chemother Pharmacol Vol. 52 (2003), p.86.
4. A. Cricca, A. Marino, D. Valenti, et al: Anticancer Research Vol. 26 (2006), p.2301.
5. M. Herold, A. Haas, S. Srock, et al: Journal of Clinical Oncology Vol. 25 (2007), p. (1986).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献